Showing 6 of 36 Clinical Trials

• S2212 SCARLET

  Breast Cancer Accepting Patients

  Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study

• S2312 CARAVAN

  Prostate Cancer Accepting Patients

  A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate-resistant Prostate Cancer (MCRPC), Stratified By Aggressive Variant Signature.

• STRIDE-II

  Lower Extremity Acute Ischemia Accepting Patients

  A Study of Patients with Lower Extremity Acute Limb Ischemia to Remove Thrombus with the IndigoTM Aspiration System

• SUNRAY-01

  Lung Cancer Accepting Patients

  A Global Pivotal Placebo-Controlled Study of LY3537982 in Combination with Pembrolizumab and LY3537982 in Combination with Pembrolizumab, Pemetrexed and Platinum for the First-line treatment of Participants with KRAS G12C-Mutant Advanced Non-Small Cell Lung Cancer.

• SUNRAY-02

  Lung Cancer Accepting Patients

  A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination with Standard of Care Immunotherapy in Participants with Resected or Unresectable KRAS G12C-Mutant, NSCLC.

• WIDER

  Breast Cancer Accepting Patients

  A phase IIIb study to characterize the efficacy and safety of Adjuvant ribociclib plus endocrine therapy in a close-to-clinical practice patient population with HR+ HER2- early breast cancer.